Showing results (1561-1570 of 8,142) with videos related to

Sort By:
Pageof 815
Haematologica|March 2, 2019
p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscapeLaura Patrussi, Nagaja Capitani, Cristina Ulivieri, et al.
Haematologica|March 2, 2019
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathwaysVera Magistroni, Mario Mauri, Deborah D'Aliberti, et al.
Haematologica|March 2, 2019
Dynamic prediction of bleeding risk in thrombocytopenic preterm neonatesSusanna F Fustolo-Gunnink, Karin Fijnvandraat, Hein Putter, et al.
Haematologica|March 2, 2019
Differences and similarities in the effects of ibrutinib and acalabrutinib on platelet functionsJennifer Series, Cédric Garcia, Marie Levade, et al.
Haematologica|March 2, 2019
Deletion of a flippase subunit Tmem30a in hematopoietic cells impairs mouse fetal liver erythropoiesisFan Yang, Yumin Huang, Xianda Chen, et al.
Haematologica|March 2, 2019
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practiceCarmen Fava, Giovanna Rege-Cambrin, Irene Dogliotti, et al.
Haematologica|November 24, 2018
Trypsin-encoding PRSS1-PRSS2 variations influence the risk of asparaginase-associated pancreatitis in children with acute lymphoblastic leukemia: a Ponte di Legno toxicity working group reportBenjamin O Wolthers, Thomas L Frandsen, Chirag J Patel, et al.
Haematologica|November 24, 2018
Sphingolipid dysregulation due to lack of functional KDSR impairs proplatelet formation causing thrombocytopeniaTadbir K Bariana, Veerle Labarque, Jessica Heremans, et al.
Haematologica|February 16, 2019
Dimeric ferrochelatase bridges ABCB7 and ABCB10 homodimers in an architecturally defined molecular complex required for heme biosynthesisNunziata Maio, Ki Soon Kim, Gregory Holmes-Hampton, et al.
Haematologica|August 11, 2019
An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimensFrancesca Schieppati, Piera Balzarini, Simona Fisogni, et al.
Pageof 815